Can hepatitis b patients stop treatment? trial tests safety of medication break
NCT ID NCT04782375
Summary
This study is testing whether some adults with chronic hepatitis B can safely stop their long-term antiviral medication. Researchers will follow 140 patients who stop treatment and compare them to 700 similar patients who continue medication. The goal is to see if stopping is safe for patients who currently have very low virus levels and no liver scarring, with careful monitoring and restarting treatment if needed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
-
Chung-Ang University Hospital
Seoul, South Korea
-
Konkuk University Hospital
Seoul, South Korea
-
Korea University Guro Hospital
Seoul, South Korea
-
Kyung-Hee University Hospital
Seoul, South Korea
-
Kyungpook National University Hospital
Daegu, South Korea
-
Samsung Medical center
Seoul, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Ulsan University Hospital
Ulsan, South Korea
Conditions
Explore the condition pages connected to this study.